on Bb Biotech (isin : CH0038389992)
BB Biotech AG's AGM Approves Proposals and Dividend
BB Biotech AG's Annual General Meeting saw shareholders unanimously approve all board proposals, including a dividend of CHF 2.25 per share. The approved dividend is scheduled for payment on March 25, 2026, with March 24 as the record date and March 23 marking the ex-dividend date. This decision reflects the confidence shareholders have in BB Biotech's strategic direction and financial health.
In addition to the dividend decision, the AGM re-elected the existing board, led by Chairman Dr. Thomas von Planta, for another one-year term. Joining him are board members Prof. Dr. Mads Krogsgaard Thomsen, Laura Hamill, Dr. Pearl Huang, and Camilla Soenderby.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Bb Biotech news